heparin: be contraindicated in hypertension

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.72
, blood
Weight: 0.57
, agent
Weight: 0.56
, molecule
Weight: 0.56
Siblings acetaminophen
Weight: 0.37
, fentanyl
Weight: 0.37
, warfarin
Weight: 0.36
, vancomycin
Weight: 0.36

Related properties

Property Similarity
be contraindicated in hypertension 1.00
be contraindicated in endocarditis 0.90
contraindicated in subarachnoid hemorrhage 0.88
induced thrombocytopenia cause thrombosis 0.81
be used before warfarin 0.78
be preferred over warfarin 0.77
be administered concurrently with warfarin 0.76
safer than warfarin 0.75
is medication 0.75
is high-alert medication 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.47
Similarity weight: 1.00
Evidence: 0.74
¬ Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.73
¬ Remarkable(warfarin, be contraindicated in hypertension)
0.05
Rule weight: 0.13
Evidence weight: 0.44
Similarity weight: 0.90
Evidence: 0.74
¬ Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.76
¬ Remarkable(warfarin, be contraindicated in endocarditis)
0.03
Rule weight: 0.13
Evidence weight: 0.30
Similarity weight: 0.75
Evidence: 0.74
¬ Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.95
¬ Remarkable(warfarin, is medication)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.73
Remarkable(warfarin, be contraindicated in hypertension)
Evidence: 0.85
¬ Plausible(warfarin, be contraindicated in hypertension)
0.51
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.90
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.76
Remarkable(warfarin, be contraindicated in endocarditis)
Evidence: 0.82
¬ Plausible(warfarin, be contraindicated in endocarditis)
0.45
Rule weight: 0.60
Evidence weight: 1.00
Similarity weight: 0.75
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.95
Remarkable(warfarin, is medication)
Evidence: 0.32
¬ Plausible(warfarin, is medication)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.90
¬ Salient(heparin, be contraindicated in hypertension)

Similarity expansion

0.69
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.90
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.89
¬ Salient(heparin, be contraindicated in endocarditis)
0.68
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.88
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.88
¬ Salient(heparin, contraindicated in subarachnoid hemorrhage)
0.64
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.75
Evidence: 0.79
Typical(heparin, be contraindicated in hypertension)
Evidence: 0.04
¬ Typical(heparin, is medication)
0.64
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.90
Evidence: 0.79
Typical(heparin, be contraindicated in hypertension)
Evidence: 0.78
¬ Typical(heparin, be contraindicated in endocarditis)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.90
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.78
¬ Plausible(heparin, be contraindicated in endocarditis)
0.63
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.88
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.79
¬ Plausible(heparin, contraindicated in subarachnoid hemorrhage)
0.62
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.88
Evidence: 0.79
Typical(heparin, be contraindicated in hypertension)
Evidence: 0.81
¬ Typical(heparin, contraindicated in subarachnoid hemorrhage)
0.62
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.81
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.93
¬ Salient(heparin, induced thrombocytopenia cause thrombosis)
0.62
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.88
Evidence: 0.74
Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.69
¬ Remarkable(heparin, contraindicated in subarachnoid hemorrhage)
0.62
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.90
Evidence: 0.74
Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.73
¬ Remarkable(heparin, be contraindicated in endocarditis)
0.61
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.75
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.22
¬ Plausible(heparin, is medication)
0.61
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.75
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.48
¬ Salient(heparin, is medication)
0.60
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.78
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.92
¬ Salient(heparin, be used before warfarin)
0.60
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.75
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.69
¬ Salient(heparin, is high-alert medication)
0.59
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.77
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.96
¬ Salient(heparin, be preferred over warfarin)
0.59
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.76
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.91
¬ Salient(heparin, be administered concurrently with warfarin)
0.59
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.75
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.85
¬ Salient(heparin, safer than warfarin)
0.56
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.81
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.84
¬ Plausible(heparin, induced thrombocytopenia cause thrombosis)
0.56
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.81
Evidence: 0.79
Typical(heparin, be contraindicated in hypertension)
Evidence: 0.86
¬ Typical(heparin, induced thrombocytopenia cause thrombosis)
0.56
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.75
Evidence: 0.79
Typical(heparin, be contraindicated in hypertension)
Evidence: 0.59
¬ Typical(heparin, is high-alert medication)
0.56
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.75
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.59
¬ Plausible(heparin, is high-alert medication)
0.56
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.81
Evidence: 0.74
Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.71
¬ Remarkable(heparin, induced thrombocytopenia cause thrombosis)
0.55
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.75
Evidence: 0.79
Typical(heparin, be contraindicated in hypertension)
Evidence: 0.65
¬ Typical(heparin, safer than warfarin)
0.55
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.78
Evidence: 0.74
Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.62
¬ Remarkable(heparin, be used before warfarin)
0.55
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.75
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.70
¬ Plausible(heparin, safer than warfarin)
0.54
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.78
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.86
¬ Plausible(heparin, be used before warfarin)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.78
Evidence: 0.79
Typical(heparin, be contraindicated in hypertension)
Evidence: 0.90
¬ Typical(heparin, be used before warfarin)
0.53
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.79
Typical(heparin, be contraindicated in hypertension)
Evidence: 0.83
¬ Typical(heparin, be administered concurrently with warfarin)
0.53
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.82
¬ Plausible(heparin, be administered concurrently with warfarin)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.74
Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.72
¬ Remarkable(heparin, be preferred over warfarin)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.89
¬ Plausible(heparin, be preferred over warfarin)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.79
Typical(heparin, be contraindicated in hypertension)
Evidence: 0.91
¬ Typical(heparin, be preferred over warfarin)
0.53
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.76
Evidence: 0.74
Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.71
¬ Remarkable(heparin, be administered concurrently with warfarin)
0.53
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.75
Evidence: 0.74
Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.69
¬ Remarkable(heparin, is high-alert medication)
0.51
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.75
Evidence: 0.74
Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.80
¬ Remarkable(heparin, safer than warfarin)
0.48
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.75
Evidence: 0.74
Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.96
¬ Remarkable(heparin, is medication)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.90
Salient(heparin, be contraindicated in hypertension)
Evidence: 0.79
¬ Typical(heparin, be contraindicated in hypertension)
Evidence: 0.74
¬ Remarkable(heparin, be contraindicated in hypertension)

Typical implies Plausible

0.40
Rule weight: 0.48
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.78
Plausible(heparin, be contraindicated in hypertension)
Evidence: 0.79
¬ Typical(heparin, be contraindicated in hypertension)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 0.75
Evidence: 0.74
¬ Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.09
¬ Typical(warfarin, is medication)
0.05
Rule weight: 0.14
Evidence weight: 0.36
Similarity weight: 1.00
Evidence: 0.74
¬ Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.87
¬ Typical(warfarin, be contraindicated in hypertension)
0.05
Rule weight: 0.14
Evidence weight: 0.40
Similarity weight: 0.90
Evidence: 0.74
¬ Remarkable(heparin, be contraindicated in hypertension)
Evidence: 0.82
¬ Typical(warfarin, be contraindicated in endocarditis)